Spur Therapeutics

Develops gene therapies for people with chronic and debilitating diseases

Stevenage, United KingdomFounded 2015spurtherapeutics.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-01

About Spur Therapeutics

Spur Therapeutics is a clinical-stage biotechnology company developing gene therapies for chronic and debilitating conditions. Its approach uses gene expression, packaging and delivery to develop genetic medicines.

The company’s programs include a gene therapy candidate for Gaucher disease and research into forms of Parkinson’s disease, dementia and cardiovascular disease. It was founded in 2015 and is headquartered in Stevenage, United Kingdom, with colleagues in the United States and United Kingdom.

Product: Clinical-stage gene therapy candidates for Gaucher disease and other chronic conditions.

Jobs at Spur Therapeutics

No open positions listed right now.

Leadership

More biotech & pharma companies

  • Spybiotech

    Develops vaccines against infectious diseases and cancer using its SpyTag/SpyCatcher protein superglue platform
    Oxford, United KingdomBiotech & pharmaFounded 2017
    New on Evolc
  • Sterling Pharma Solutions

    Develops and manufactures active pharmaceutical ingredients for biotech and pharmaceutical companies
    Cramlington, United KingdomBiotech & pharmaFounded 200617 open jobs
    New on Evolc
  • Storm Therapeutics

    Clinical-stage biotech developing small-molecule RNA modifying enzyme inhibitors for cancer and other diseases
    Waterbeach, United KingdomBiotech & pharmaFounded 2015
    New on Evolc
  • Sygnature Discovery

    Contract drug discovery services for biotech and pharma firms, spanning chemistry, biology, structural work and preclinical studies
    Nottingham, United KingdomBiotech & pharmaFounded 200413 open jobs
    New on Evolc
  • Synthace

    Experiment design, lab automation and AI-ready data software for drug discovery and life science R&D teams
    London, United KingdomBiotech & pharmaFounded 2011
    New on Evolc
  • T-Cypher Bio

    Develops immune engager drugs for cancer and autoimmune diseases, built on proprietary wet-lab and computational platforms
    Abingdon, United KingdomBiotech & pharmaFounded 2015
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Analytics

  • Google Tag ManagerMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content delivery

Content management

  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Forms

  • Gravity FormsHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Hosting

Privacy & consent

  • CookiebotHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.